Ondine Biomedical Inc Working Capital to Net Assets Ratio

Latest as of June 2026: 132.9%

Ondine Biomedical Inc working capital to net assets ratio. Ondine Biomedical Inc (OBI) has a Working Capital to Net Assets ratio of 132.9% as of June 2026. Working capital of GBX-4.28 Million (current assets of GBX7.89 Million minus current liabilities of GBX12.17 Million) is measured against net assets of GBX-3.22 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Ondine Biomedical Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

132.9%
Working Capital / Net Assets

Working Capital

GBX-4.28 Million
GBX

Current Assets

GBX7.89 Million
GBX

Current Liabilities

GBX12.17 Million
GBX

Working Capital to Net Assets Ratio of Ondine Biomedical Inc (2001–2025)

Working capital to net assets ratio of Ondine Biomedical Inc from 2001 to 2025. This chart shows how Ondine Biomedical Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2001 to 2025. As of June 2026, the ratio stands at 132.9%, reflecting working capital of GBX-4.28 Million against net assets of GBX-3.22 Million GBX. See how many days can Ondine Biomedical Inc fund operations to measure how many days the company can operate on defensive assets alone.

Ondine Biomedical Inc Working Capital to Net Assets Ratio by Year (2001–2025)

Ondine Biomedical Inc working capital to net assets ratio by year from 2001 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Ondine Biomedical Inc from 2001 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see OBI current and non-current assets.

Year WC/NA Ratio Working Capital (GBX) Net Assets Current Assets Current Liabilities Change (pp)
2025 70.8% GBX2.47 Million GBX3.49 Million GBX13.28 Million GBX10.81 Million ▼ -20.0 pp
2024 90.8% GBX6.24 Million GBX6.88 Million GBX12.19 Million GBX5.95 Million ▲ +30.3 pp
2023 60.4% GBX1.26 Million GBX2.08 Million GBX4.75 Million GBX3.49 Million ▼ -35.9 pp
2022 96.4% GBX11.22 Million GBX11.64 Million GBX15.13 Million GBX3.91 Million ▼ -3.4 pp
2021 99.7% GBX29.58 Million GBX29.66 Million GBX33.50 Million GBX3.92 Million ▼ -0.9 pp
2020 100.6% GBX-34.04 Million GBX-33.83 Million GBX1.75 Million GBX35.78 Million ▼ -5.5 pp
2019 106.1% GBX-27.66 Million GBX-26.07 Million GBX1.01 Million GBX28.67 Million ▼ -6.2 pp
2018 112.3% GBX-20.11 Million GBX-17.90 Million GBX2.29 Million GBX22.40 Million ▼ -30.2 pp
2017 142.5% GBX-9.33 Million GBX-6.55 Million GBX2.82 Million GBX12.15 Million ▲ +309.3 pp
2010 -166.8% GBX-465.70K GBX279.19K GBX1.64 Million GBX2.11 Million ▼ -188.7 pp
2009 21.9% GBX279.44K GBX1.28 Million GBX1.56 Million GBX1.28 Million ▼ -19.6 pp
2008 41.5% GBX554.68K GBX1.34 Million GBX2.05 Million GBX1.50 Million ▼ -49.7 pp
2007 91.1% GBX9.88 Million GBX10.84 Million GBX11.90 Million GBX2.01 Million ▼ -3.7 pp
2006 94.9% GBX15.74 Million GBX16.59 Million GBX17.58 Million GBX1.84 Million ▼ -2.0 pp
2005 96.9% GBX15.99 Million GBX16.50 Million GBX16.69 Million GBX702.68K ▲ +7401.3 pp
2003 -7304.5% GBX16.63 Million GBX-227.62K GBX16.86 Million GBX233.99K ▼ -7404.5 pp
2002 100.0% GBX-143.28K GBX-143.28K GBX845.00 GBX144.13K ▲ +103.6 pp
2001 -3.6% GBX-50.17K GBX1.39 Million GBX7.84K GBX58.02K —
pp = percentage points